The relationship between osteoporosis treatment history and receipt of a second zoledronic acid dose
Konstantelos N, Kim S, Cheung AM, Burden AM, Grootendorst P, Cadarette SM. Osteoporos Int. 2025 Sep 4 [Epub ahead of print].
Publications
Kidney injury during treatment with aflibercept versus ranibizumab: a population-based study
Campbell RJ, El-Defrawy SR, Gill SS, Shellenberger J, Whitehead M, Bell CM, Bronskill SE, Paterson JM, McIsaac MA. Retina. 2025; Sep 3 [Epub ahead of print].
Real-world outcomes of transplant ineligible older adults with multiple myeloma treated with novel regimens: a population-based retrospective cohort study
Abdallah N, Mian H, Seow H, Pond GP, Gayowsky A, Visram A, Costa LJ, Wildes TM, Fonseca R, Pawlyn C, Cook G, Kumar S, Chakraborty R. Am J Hematol. 2025; Aug 29 [Epub ahead of print].
Outcomes following exposure to drug interactions with ibrutinib in patients with chronic lymphocytic leukaemia
Hoang T, Cheung MC, Juurlink DN, Chan KKW, Lau C, Liu N, Abdel-Qadir H, Prica A, Hay AE, Vijenthira A, Mozessohn L. Br J Haematol. 2025; Aug 29 [Epub ahead of print].
Circumstances surrounding alcohol toxicity deaths and prior pharmacotherapy for alcohol use disorder in Ontario, Canada
Wynne W, Iacono A, Yang J, Hamzat B, Leece P, Kolla G, Boyd R, Bozinoff N, Franklyn M, Shearer D, Smoke A, Wu F, Newcombe P, Gomes T. Alcohol Alcohol. 2025; 60(5):agaf055.
Evaluating regional and temporal variations in quality indicators for opioid initiation and pharmacist medication reviews in Ontario: a population-based repeated cross-sectional study
Torabi A, Chu C, Abdul Aziz Y, Yada N, Chaudhry S, Wang T, Gomes T, Tadrous M. Can Pharm J (Ott). 2025; 17151635251358873. Epub 2025 Aug 22.
Trends in the dispensing of opioids for pain and concurrent benzodiazepine use among First Nations People in Ontario, Canada, from 2013 to 2021
Holton A, Wang T, Hamzat B, Bragg S, deGonzague B, Mecredy G, Campbell T, Antoniou T, McGregor L, Bertram J, Gomes T. Can J Public Health. 2025; Aug 18 [Epub ahead of print].
Initiation and dose of methadone monotherapy vs combination therapy, 2015 to 2023
Garg R, Luo J, Bozinoff N, Sproule B, Antoniou T, Wyman J, Munro C, Gomes T. JAMA Netw Open. 2025; 8(8):e2527290.
Omission of anthracyclines from neoadjuvant chemotherapy for breast cancer: a population-based analysis
Mata DGMM, Sutradhar R, Castelo M, Hahn E, Nguyen L, Rodin D, Fatiregun O, Trebinjac S, Paszat L, Eisen A, Jerzak KJ, Rakovitch E. Breast Cancer Res Treat. 2025 Aug 13 [Epub ahead of print].
Association between dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists and COVID-19 infection and adverse outcomes: a cohort study
Thompson W, Yu B, Porter J, Fang J, Ferreira-Legere LE, Austin PC, Jackevicius CA, Ross H, Lee DS, Weisman A, Farkouh ME, Gershon AS, Atzema CL, Kwong JC, Ha A, Džavík V, Udell JA. BMJ Open Diabetes Res Care. 2025; 13(4):e004677.